| Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia MJ Manco-Johnson, TC Abshire, AD Shapiro, B Riske, MR Hacker, ... New England Journal of Medicine 357 (6), 535-544, 2007 | 2251 | 2007 |
| A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group GL Bray, ED Gomperts, S Courter, R Gruppo, EM Gordon, ... | 520 | 1994 |
| Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A J Mahlangu, JS Powell, MV Ragni, P Chowdary, NC Josephson, ... Blood, The Journal of the American Society of Hematology 123 (3), 317-325, 2014 | 516 | 2014 |
| Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery AD Shapiro, GS Gilchrist, WK Hoots, HA Cooper, DA Gastineau Thrombosis and haemostasis 80 (11), 773-778, 1998 | 491 | 1998 |
| Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors NS Key, LM Aledort, D Beardsley, HA Cooper, G Davignon, ... Thrombosis and haemostasis 80 (12), 912-918, 1998 | 447 | 1998 |
| Modern haemophilia care E Berntorp, AD Shapiro The Lancet 379 (9824), 1447-1456, 2012 | 424 | 2012 |
| Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study SW Pipe, M Shima, M Lehle, A Shapiro, S Chebon, K Fukutake, NS Key, ... The Lancet Haematology 6 (6), e295-e305, 2019 | 347 | 2019 |
| Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation WP Fay, AD Shapiro, JL Shih, RR Schleef, D Ginsburg New England Journal of Medicine 327 (24), 1729-1733, 1992 | 342 | 1992 |
| Rare bleeding disorders: diagnosis and treatment R Palla, F Peyvandi, AD Shapiro Blood, The Journal of the American Society of Hematology 125 (13), 2052-2061, 2015 | 312 | 2015 |
| Consensus perspectives on prophylactic therapy for haemophilia: summary statement E Berntorp, J Astermark, S Björkman, VS Blanchette, K Fischer, ... Haemophilia 9, 1-4, 2003 | 292 | 2003 |
| Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene WP Fay, AC Parker, LR Condrey, AD Shapiro Blood, The Journal of the American Society of Hematology 90 (1), 204-208, 1997 | 290 | 1997 |
| Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients AD Shapiro, MV Ragni, LA Valentino, NS Key, NC Josephson, JS Powell, ... Blood, The Journal of the American Society of Hematology 119 (3), 666-672, 2012 | 257 | 2012 |
| Factor IX inhibitors and anaphylaxis in hemophilia B I Warrier, BM Ewenstein, MA Koerper, A Shapiro, N Key, D DiMichele, ... Journal of pediatric hematology/oncology 19 (1), 23-27, 1997 | 219 | 1997 |
| Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and-independent mechanisms WP Fay, DT Eitzman, AD Shapiro, EL Madison, D Ginsburg | 194 | 1994 |
| Haemophilia E Berntorp, K Fischer, DP Hart, ME Mancuso, D Stephensen, AD Shapiro, ... Nature reviews Disease primers 7 (1), 45, 2021 | 190 | 2021 |
| Efficacy and safety of OBI‐1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A R Kruse‐Jarres, J St‐Louis, A Greist, A Shapiro, H Smith, P Chowdary, ... Haemophilia 21 (2), 162-170, 2015 | 190 | 2015 |
| Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease … R Kulkarni, JM Soucie, J Lusher, R Presley, A Shapiro, J Gill, ... Haemophilia 15 (6), 1281-1290, 2009 | 190 | 2009 |
| Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry R Parameswaran, AD Shapiro, JC Gill, CM Kessler, ... Haemophilia 11 (2), 100-106, 2005 | 179 | 2005 |
| Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin‐free method: pharmacokinetics, efficacy, and safety in previously treated … MD Tarantino, PW Collins, CRM Hay, AD Shapiro, RA Gruppo, E Berntorp, ... Haemophilia 10 (5), 428-437, 2004 | 179 | 2004 |
| Plasma and albumin‐free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients VS Blanchette, AD Shapiro, RJ Liesner, FH Navarro, I Warrier, PC Schroth, ... Journal of Thrombosis and Haemostasis 6 (8), 1319-1326, 2008 | 176 | 2008 |
